Evaluating the feasibility of implementing a prescription drug misuse prevention intervention in the community: a mixed methods study by Tamara Al Rawwad, Vaishnavi Tata, Matthew A. Wanat, Danielle Campbell, Douglas Thornton

Connect to this object online.

Differences between pharmacists' perception of counseling and practice in the era of prescription drug misuse by J. Douglas Thornton, Precious Anyanwu, Vaishnavi Tata, Tamara Al Rawwad, Marc L. Fleming

Connect to this object online.

Intention to get naloxone among patients prescribed opioids for chronic pain by Yinan Huang, Ning Lyu, Shrey Gohil, Shweta Bapat, E. James Essien, J. Douglas Thornton

Connect to this object online.

Helpful, Unnecessary, or Harmful: A Systematic Review of the Effects of Prescription Drug Monitoring Program Use on Opioid Prescriptions by Nina Z. Y. Smith, J. Douglas Thornton, Susan H. Fenton, Debora Simmons, Tiffany Champagne-Langabeer

Connect to this object online.

Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis by Vaishnavi Tata, Randa Al Saadi, Sang Kyu Cho, Tyler J. Varisco, Matthew Wanat, J. Douglas Thornton

Connect to this object online.

Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis by Jagadeswara Rao Earla, George J. Hutton, J. Douglas Thornton, Hua Chen, Michael L. Johnson, Rajender R. Aparasu

Connect to this object online.

Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy by Tyler J. Varisco, Hannah Fish, Joshua Bolin, David Dadiomov, Lucas G. Hill, Ekere J. Essien, Matthew A. Wanat, Diane Ginsburg, Jeanne Waggener, Sahar Yazdanfard, Juhyeon Song, Whanhui Chi, Douglas Thornton

Connect to this object online.